146 related articles for article (PubMed ID: 9142198)
1. Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features.
Kerbl R; Urban CE; Ladenstein R; Ambros IM; Spuller E; Mutz I; Amann G; Kovar H; Gadner H; Ambros PF
Med Pediatr Oncol; 1997 Jul; 29(1):1-10. PubMed ID: 9142198
[TBL] [Abstract][Full Text] [Related]
2. [5 years neuroblastoma screening in Austria: rate of participation, results and a comparison with other screening areas].
Kerbl R; Urban CE; Ladenstein R; Schnellauf C; Sitzwohl C; Lackner H; Gleispach H; Fauler G; Ambros PF; Ambros IM; Rumpler S; Gadner H; Spuller E; Höfler G; Amann G; Kytir J; Mutz I
Wien Klin Wochenschr; 1996; 108(13):398-403. PubMed ID: 8766424
[TBL] [Abstract][Full Text] [Related]
3. Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.
Okazaki T; Kohno S; Mimaya J; Hasegawa S; Urushihara N; Yoshida A; Kawano S; Kusafuka J; Horikoshi Y; Takashima Y; Aoki K; Hamazaki M
Pediatr Surg Int; 2004 Jan; 20(1):27-32. PubMed ID: 14689211
[TBL] [Abstract][Full Text] [Related]
4. Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.
Nakagawara A; Zaizen Y; Ikeda K; Suita S; Ohgami H; Nagahara N; Sera Y; Akiyama H; Kawakami K; Uchino J
Cancer; 1991 Nov; 68(9):2037-44. PubMed ID: 1913552
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of screening for neuroblastoma at 6 months of age: a retrospective population-based cohort study.
Hiyama E; Iehara T; Sugimoto T; Fukuzawa M; Hayashi Y; Sasaki F; Sugiyama M; Kondo S; Yoneda A; Yamaoka H; Tajiri T; Akazawa K; Ohtaki M
Lancet; 2008 Apr; 371(9619):1173-80. PubMed ID: 18395578
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors.
Kerbl R; Urban CE; Ambros IM; Dornbusch HJ; Schwinger W; Lackner H; Ladenstein R; Strenger V; Gadner H; Ambros PF
J Clin Oncol; 2003 Nov; 21(22):4228-34. PubMed ID: 14615452
[TBL] [Abstract][Full Text] [Related]
7. Screening for neuroblastoma in North America. Preliminary results of a pathology review from the Quebec Project.
Takeuchi LA; Hachitanda Y; Woods WG; Tuchman M; Lemieux B; Brisson L; Bernstein M; Brossard J; Leclerc JM; Byrne TD
Cancer; 1995 Dec; 76(11):2363-71. PubMed ID: 8635044
[TBL] [Abstract][Full Text] [Related]
8. Which cases are found and missed by neuroblastoma screening at 1 year? Results from the 1992 to 1995 study in three Federal States of Germany.
Berthold F; Baillot A; Hero B; Schurr P; Nerenz A; Hunneman DH; Sander J
J Clin Oncol; 1999 Apr; 17(4):1200. PubMed ID: 10561179
[TBL] [Abstract][Full Text] [Related]
9. Screening for neuroblastoma: a review of the evidence.
Chamberlain J
J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
[TBL] [Abstract][Full Text] [Related]
10. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
[TBL] [Abstract][Full Text] [Related]
11. One hundred neuroblastomas detected through a mass screening system in Japan.
Hachitanda Y; Ishimoto K; Hata J; Shimada H
Cancer; 1994 Dec; 74(12):3223-6. PubMed ID: 7982186
[TBL] [Abstract][Full Text] [Related]
12. [Present status of neuroblastoma mass screening in Japan. Neuroblastoma-Committee of the Japanese Childhood Cancer Society].
Sawada T; Nagahara N; Ohi R; Yamamoto K; Okabe I; Hanawa Y; Hashizume K; Matsui I; Ohkawa H; Tunoda A
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2319-26. PubMed ID: 2260868
[TBL] [Abstract][Full Text] [Related]
13. Screening for neuroblastoma in late infancy by use of EIA (enzyme-linked immunoassay) method: 115000 screened infants in Austria.
Kerbl R; Urban CE; Ambros PF; Lackner H; Ladenstein R; Spuller E; Mutz I; Ambros I; Amann G; Gadner H; Parker L
Eur J Cancer; 1996 Dec; 32A(13):2298-305. PubMed ID: 9038613
[TBL] [Abstract][Full Text] [Related]
14. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
[TBL] [Abstract][Full Text] [Related]
15. A population-based study of the usefulness of screening for neuroblastoma.
Woods WG; Tuchman M; Robison LL; Bernstein M; Leclerc JM; Brisson LC; Brossard J; Hill G; Shuster J; Luepker R; Byrne T; Weitzman S; Bunin G; Lemieux B
Lancet; 1996 Dec 21-28; 348(9043):1682-7. PubMed ID: 8973429
[TBL] [Abstract][Full Text] [Related]
16. Neuroblastoma of the urinary bladder, preclinically detected by mass screening.
Yokoyama S; Hirakawa H; Ueno S; Yabe H; Hiraoka N
Pediatrics; 1999 May; 103(5):e67. PubMed ID: 10224211
[TBL] [Abstract][Full Text] [Related]
17. Screening for neuroblastoma in France: methodological aspects and preliminary observations.
Chauvin F; Mathieu P; Frappaz D; Lasset C; Favrot MC; Greffe J; Esteve J; Thiesse P; Combaret V; Chauvot P; Boschetti R; David L; Brunat-Mentigny M; Philip T
Med Pediatr Oncol; 1997 Feb; 28(2):81-91. PubMed ID: 8986143
[TBL] [Abstract][Full Text] [Related]
18. Neuroblastoma screening in the United States: results of the Texas Outreach Program for neuroblastoma screening.
Ater JL; Gardner KL; Foxhall LE; Therrell BL; Bleyer WA
Cancer; 1998 Apr; 82(8):1593-602. PubMed ID: 9554539
[TBL] [Abstract][Full Text] [Related]
19. Mass-screening of neuroblastoma using urine from infants by high-performance liquid chromatographic method: results of first (6th month) and second (14th month) screening.
Takeda T; Shimada M; Nishi M; Hanai J; Kikuchi Y
J Neurooncol; 1997 Jan; 31(1-2):165-70. PubMed ID: 9049845
[TBL] [Abstract][Full Text] [Related]
20. A 5-year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observations.
Mathieu P; Frappaz D; Chauvin F; Combaret V; Vercherat M; Brunat-Mentigny M; David L; Esteve J; Favrot M; Fouillat V; Greffe J; Lasset C; Renaud P; Philip T
Early Hum Dev; 1996 Sep; 46(1-2):177-96. PubMed ID: 9019414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
